The diabetic retinopathy market will witness significant expansion through the next few years with the prevalence of diabetic conditions across developing countries. Diabetes can be touted as a medical disorder that involves associated complications, with diabetic retinopathy among the most frequent in comparison to others.
As per the International Diabetes Federation, there were over 463 million individuals diagnosed with diabetes in 2019. Statistics also reveal that more than 80% of the diabetic population post 20 years of diagnosis are prone to diabetic retinopathy.
Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/486
Annual revenue from the proliferative diabetic retinopathy market is likely to reach a CAGR of 7.5% through the coming years. Proliferative diabetic retinopathy (PDR) is a chronic diabetic condition in its most advanced phase that affects the eyes of the infected individuals and pushes the need for surgical procedures to improve vision. An analysis by Apollo Hospitals suggested that people over 60 years of age show a higher tendency of acquiring this disease.
It is pivotal to remember if left untreated for long, diabetic retinopathy can evolve to become visual threatening diabetic retinopathy (VTDR), which has been identified by the NCBI to be one of the leading causes of blindness around the world. Studies by NCBI attributed 37.3 million cases of blindness due to VTDR, which may increase to 56.3 million in 2030. However, it is prudent to note that an unhealthy lifestyle is not the only cause of this disorder – the patient’s advancing age plays a major role as well to cause diabetic retinopathy or age related macular degeneration (AMD). Thus, diabetic retinopathy market will continue to depict an upward trend between 2019 and 2025 not only because of the increasing cases of diabetes and AMD but also because of rising awareness about diabetic retinopathy and its blindness-causing abilities.
North America is home to an expanding geriatric population base affected by chronic diseases like diabetes and the regional industry was responsible for close to USD 3 billion in revenues for diabetic retinopathy industry in 2018. The growth can be attributed to the strong possibility of this patient pool to acquire diabetic retinopathy resulting in higher consumption of advanced medication across this region.
Innovation in medical technologies to combat this dreaded disease is expected positively impact diabetic retinopathy market. With a major upsurge in the prevalence of diabetes and growing elderly population susceptible to lifestyle diseases, it is expected that dynamic research and development in the field of diabetic retinopathy will be reinvigorated, thereby stimulating diabetic retinopathy market size in the ensuing years.
Request for a Customization of this research report @ https://www.decresearch.com/roc/486
Partial Chapter of the Table of Content
Chapter 4. Diabetic Retinopathy Market, By Type
4.1. Key segment trends
4.2. Proliferative diabetic retinopathy
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.3. Non-proliferative retinopathy
4.3.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Diabetic Retinopathy Market, By Age Group
5.1. Key segment trends
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Diabetic Retinopathy Market, By Management
6.1. Key segment trends
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Intraocular Steroid Injection
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Laser Surgery
126.96.36.199. Market size, by region, 2014-2025 (USD Million)
188.8.131.52. Market size, by region, 2014-2025 (USD Million)
Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/diabetic-retinopathy-market-report